Our study aimed at finding a mechanistic relationship between the gut microbiome and breast cancer. Breast cancer cells are not in direct contact with these microbes, but disease could be influenced by bacterial metabolites including secondary bile acids that are exclusively synthesized by the microbiome and known to enter the human circulation. In murine and bench experiments, a secondary bile acid, lithocholic acid (LCA), reduced cancer cell proliferation (by 10-20%) and VEGF production (by 37%), aggressiveness and metastatic potential of primary tumors through inducing mesenchymal-to-epithelial transition, increased antitumor immune response, OXPHOS and the TCA cyle. Part of these effects was due to activation of TGR5 by LCA. Early stage breast cancer patients, versus control women, had reduced serum LCA levels, reduced chenodeoxycholic acid to LCA ratio, and reduced abundance of the baiH (7α/β-hydroxysteroid dehydroxylase, the key enzyme in LCA generation) gene in fecal DNA, all suggesting reduced microbial generation of LCA in early breast cancer.
Introduction
The human body harbors a vast number of symbiotic, commensal and pathogenic bacteria in the bodily cavities and the body surface. The ensemble of these microbes is referred as the microbiota and its collective genome as the microbiome. Recent advances pointed out that changes in the composition of the microbiome and certain bacterial metabolites crucially impact metabolic, behavioral, cardiovascular and immune functions of the host and have pivotal roles in diseases that were previously not associated with bacteria [1] [2] [3] [4] . Alterations of the microbiome are associated with certain cancers. Although, the microbiota may have a widespread role in carcinogenesis, the number of directly tumorigenic bacteria is extremely small, some 10 bacterial species fall into this category [5] . It seems more likely that pathological changes in the microbiota/microbiome (dysbiosis) determine susceptibility to the disease or influence the progression of the disease [4] .
Most of these cancers affect those organs that are directly in contact with microbes such as the urinary tract [6] , cervix [7] , skin [8] , airways [9] , and the colon [4] . Such microbiomehost interactions are best characterized in the colon. In the intestine a breach of the biological barrier between the microbes and the underlying tissues enables an adverse physical contact between microbes and host cells, that induces the production of paracrine bacterial metabolites [4] . Through these, the microbiome modulates tumorigenesis, tumor promotion, severity of the disease, and chemotherapy effectiveness in colonic tumors [4] .
Direct stimulation of the cancer cells by bacteria probably has role in bacteria-mediated induction of lymphomas [10, 11] and possibly prostate cancer [6] .
Much less is known of the role of the microbiome in the regulation of those tumors that are located to different compartments and are indirectly connected to the microbiome through the circulation. Changes in the microbiome is associated with metabolic diseases (e.g. obesity or type II diabetes) [12] . These metabolic diseases are risk factors of certain cancers, among them, breast cancer [13, 14] . It is likely that similar mechanisms can confer susceptibility to cancer as to metabolic diseases. Blood-borne bacterial metabolites (e.g.
short chain fatty acids) mediate human metabolism, hence these metabolites are likely candidates to be transported to a potential tumor by the bloodstream to exert carcinogenic or anti-carcinogenic effects in distant tumors. For hepatocellular carcinoma, lipopolysaccharide [15] and deoxycholic acid (DCA) [16] have been identified as promoters, while propionate, a short chain fatty acid (SCFA), is an inhibitor [17] .
Numerous bacterial metabolites have been identified that are either the microbes' own metabolites (e.g., short chain fatty acids, lactate, pyruvate) or modified products of the host (e.g., secondary bile acids, metabolites of aromatic amino acids, redox-modified sex steroids) [18] [19] [20] . These bioactive metabolites act through various pathways that involve the modification of gene expression (e.g., activation of histone deacetylases and other lipid-
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4 mediated transcription factors) or the modulation of signal transduction in the host. Our aim with the current study was to investigate a potential causal link between changes in the microbiome, microbiome-derived metabolites and breast cancer.
Materials and methods

Chemicals
All chemicals were from Sigma-Aldrich (St. Louis, MO, USA) unless otherwise stated.
Radioactively labelled substrates for the pulse-chase metabolomics experiment were from Cambridge Isotope Laboratories, Andover, MA, USA. The inhibitors and antagonists used in the TGR5 experiments (U73343 (phospholipase C inhibitor), NF449 (G sα -selective antagonist), CINPA1 (CAR antagonist), DY268 (FXR antagonist), GSK2033 (LXR antagonist)) were obtained from Tocris Bioscience and were used at the concentration of 5 µM except for U73343 which was used at a final concentration of 1 µM.
Image based correlation spectroscopy (ImFCS)
After an exponential of polynomial bleach correction, pixel-by-pixel autocorrelation functions (ACFs) were calculated using a multi-tau correlation scheme [21] . To obtain the diffusion coefficient (D) for all pixels ACFs were fitted according to the equation in [21] . To identify and describe the mode of membrane organization by investigating the size-dependency of diffusion coefficient, we used the Imaging FCS type of FCS diffusion law [22] . According to that, the diffusion time (τ ) of the fluorescent probe depends on the observation area ( ), as described by
where is the area of the membrane in which the labeled particle travels across,τ 0 is the intercept of the diffusion law plot on the y-axis of /D vs. . This parameter provides information about the diffusion confinement. A more detailed description of the method can be found among the Supplementary Materials.
Cell culture
MCF7 cells were maintained in MEM (Sigma-Aldrich) medium supplemented with 10 % FBS, 1 % penicillin/streptomycin and 2 mM L-glutamine at 37 °C with 5 % CO 2.
4T1 cells were maintained in RPMI-1640 (Sigma-Aldrich) medium containing 10 % FBS and 1 % penicillin/streptomycin, 2 mM L-glutamine and 1 % pyruvate at 37 °C with 5 % CO 2.
A C C E P T E D M A N U S C R I P T 5 SKBR3 cells were maintained in DMEM (Sigma-Aldrich, 1000 mg/l glucose) medium supplemented with 10 % FBS, 1 % penicillin/streptomycin and 2 mM L-glutamine at 37 °C with 5 % CO 2.
Primary fibroblasts cells were maintained in DMEM (Sigma-Aldrich, 1000 mg/l glucose) medium supplemeted with 20 % FBS, 1 % penicillin/streptomycin, 2 mM L-glutamine and 10 mM HEPES at 37 °C with 5 % CO 2 .
In vitro cell proliferation assays
Sulphorhodamine B assays were described in [23] . For colony formation assays five hundred cells were seeded in a 6-well plate in complete medium and were cultured with the indicated concentrations of LCA for 7 days. At the end of the assay plates were washed twice in PBS.
Colonies were fixed in methanol for 15 minutes, dried and stained according to MayGrünwald-Giemsa for 15 minutes. Plate was washed with water and the colonies were counted using Image J software [24] .
Detection of cell death
LCA-induced cytotoxicity was determined by propidium iodide (PI) uptake. Cells were seeded in 6-well plate (MCF7 -200.000 cell/well; 4T1 -75.000 cell/well) treated with LCA for two days and stained with 100 µg/ml propidium iodide for 30 min at 37 °C, washed once in PBS, and analyzed by flow cytometry (FACSCalibur, BD Biosciences).
Scratch assay and video microscopy
Cells were grown in 6-well plates until cell confluence reached about 70-80 %. The plates were manually scratched with sterile 200 µl pipette tip, followed by washing the cells twice with PBS. Then cells were incubated with vehicle or LCA (0.3 µM) in a thermostate. Cell densities were monitored every hour for one day using JuLi Br Live cell movie analyzer (NanoEnTek Inc., Seoul, Korea). For the assessement of the abundance of the baiH ORF 10 ng of DNA (from fecal samples) was used for qPCR reactions. Primers are listed in Table 2 . Specificity of the qPCR reactions were verified by sequencing PCR products with the primers used for the amplification.
Electric Cell-substrate Impedance Sensing (ECIS)
ECIS
Metabolomics, pulse-chase metabolomics
Cells, grown in the presence of LCA, were harvested after 48 hours of treatment. After quenching in liquid nitrogen the labelled (in D5030 medium for 1 hour were with 10 mM [U- 
Measurement of oxygen consumption and extracellular acidification rate
Oxygen consumption rate (OCR) and changes in pH, extracellular acidification rate (ECAR)
were measured using an XF96 oxymeter (Seahorse Biosciences, North Billerica, MA, USA).
Cells were seeded in 96-well Seahorse assay plate (MCF7 -3000 cells/well; 4T1 -1500 cells/well) and treated with vehicle and LCA for two days. Then oxygen consumption was recorded every 30 minutes to follow the LCA effect. Data were normalized to protein content. 
SDS-PAGE and Western blotting
Animal study
All animal experiments were authorized by the local and national ethical board (reg.
1/2015/DEMÁB) and were performed to conform the relevant EU and US guidelines.
Experimental animals were female BALB/c animals between 8-10 weeks of age (20-25 g ).
Mice were randomized for all experiments animals were. Animals were bred in the "specific pathogen free" zone of the Animal Facility at the University of Debrecen, and kept in the 
LCA treatment
Animals received daily oral LCA treatments. LCA stock was prepared in 96% ethanol at 100x concentration (7. 
Infiltration score
During autopsy tumors were visually assessed and scored based on their infiltration rate into surrounding tissues. If the tumor mass remained in the mammary fat pads without any detectable attachment to muscle tissues then it was classified as a "low infiltration" tumor. In case the tumor mass attached to the muscle tissue below the fat pad but hasn't penetrated it then it was classified as a "medium infiltration" tumor. Finally, if the tumor mass grew into the muscle tissue and penetrated the abdominal wall then it was scored a "high infiltration"
tumor. Researchers involved in scoring primary tumors for their infiltration rate were blinded.
TIL calculation
Tumor infiltrating lymphocytes (TIL) content of tumors was expressed as the number of TILs per 100 tumor cells.
Human studies
The study in which human feces samples were collected from healthy subjects and breast cancer patients was developed by collaborators at the National Cancer Institute (NCI), Kaiser
Permanente Colorado (KPCO), the Institute for Genome Sciences at the University of Maryland School of Medicine, and RTI International. The study protocol and all study materials were approved by the Institutional Review Boards at KPCO, NCI, and RTI International (IRB number 11CN235).
The study in which human serum samples were collected from healthy subjects and breast cancer patients was developed by collaborators at the University of Debrecen (Hungary).
The study protocol and all study materials were approved by the Institutional and Hungarian
Review Boards (3140-2010).
Cohort for fecal DNA and serum studies are listed in Table 4 .
Serum bile acid determination
Serum bile acid profile was assessed as in [25] .
Database search
The kmplot.com database was used to study the link between gene expression levels and breast cancer survival in humans. The association of known mutations with breast cancer was retrieved from www.intogen.org/. Gene expression profiles were retrieved from the Gene expression omnibus (www.ncbi.nlm.nih.gov/geoprofiles/). The sequence of the baiH ORF or the bai operon was retrieved from the KEGG (www.genome.jp/kegg/) and the PATRIC databases (www.patricbrc.org/).
Statistical analysis
We used two tailed Student's t-test for the comparison of two groups unless stated otherwise. Fold data were log 2 transformed to achieve normal distribution. For multiple comparisons one-way analysis of variance test (ANOVA) was used followed by Tukey's honestly significance (HSD) post-hoc test. Data is presented as average ± SD unless stated otherwise, percent changes are listed in Table 5 . Outliers were identified for Fig. S3B using the Thomson tau-test. Statistical analysis was done using GraphPad Prism VI software.
Results
Lithocholic acid attenuates the aggressiveness of experimental breast cancer
Primary bile acids are converted to secondary bile acids exclusively by the intestinal microbiota [26] . Therefore, changes elicited by secondary bile acids directly implicate the involvement of the intestinal microbiota. We investigated three secondary bile acids, lithocholic acid (LCA), deoxycholic acid (DCA) and ursodeoxycholic acid (UDCA) in concentrations corresponding to their normal (reference) concentrations in human serum and breast tissue (10 nM -10 μM) [19, 27] first in short term proliferation assays. LCA reduced cellular proliferation of MCF7, SKBR3 and 4T1 breast cancer cells but did not affect primary fibroblasts (10 nM -10 μM) (Fig. 1A , Table 5 ). Other secondary bile acids such as DCA or UDCA were without effect on MCF7 and 4T1 breast cancer cells (Fig. 1B) . In the subsequent assays we used LCA concentrations higher than the reference serum concentration of LCA (~30-50 μM) as higher LCA concentrations (100-1000 nM) were reported in the breast [27] .
The cytostatic effect of LCA was verified in longer colony forming assays (Fig. 1C , Table 5 ).
The percent of propidium-iodide positive cells did not change upon LCA treatment suggesting that LCA did not induce cell death (Fig. 1D) .
We tested the cytostatic property of LCA in mice that were grafted with 4T1 cells and were treated with LCA (15 nmol LCA p.o. q.d.) or vehicle for 18 days. At the time of the sacrifice the infiltration capacity of the primary tumor to the surrounding tissues markedly decreased upon LCA treatment ( Fig. 2A) . Furthermore, the number of the metastases was also lower in the LCA-treated group (Fig. 2B) .
LCA interferes with multiple anticancer molecular pathways
After finding the cytostatic property of LCA in breast cancer, we investigated how LCA modulates the different features of breast cancer through assessing classical hallmarks of cancer [28] .
LCA inhibited tumor infiltration and metastasis formation ( Fig. 2A-B) , implicating modulation of the epithelial-mesenchymal transition (EMT) and cellular movement. LCA treatment improved cell-to-cell connections, an epithelial feature, as reflected by epitheliallike morphology in cells (Fig. 3A, Fig. S3A ) and improved total impedance (Fig. 3B , Table 5 )
that provide functional evidence of better cell-to-surface and cell-to-cell adhesion. LCAtreatment inhibited β-catenin signaling as evidenced by lower GSK-3α and GSK-3β phosphorylation and lower β-catenin protein content both in cell lines and in vivo (Fig. 3C,   Fig. S3B ). Furthermore, LCA-treated 4T1 cells were slower in moving into a void area in a scratch assay as compared to vehicle-treated ones (Fig. 3D) . In addition, we found lower VEGF mRNA expression (Fig. 3E , Table 5 ) and higher number of tumor infiltrating lymphocytes (TILs) in LCA-treated as compared to vehicle-treated ones mice (TILs) (Fig.   3F ).
Breast cancer depends on Warburg metabolism [29] . Therefore, we assessed LCAinduced changes in cellular metabolism. LCA treatment induced glycolysis (extracellular acidification rate -ECAR) and mitochondrial respiration (oxygen consumption rate -OCR) levels (Fig. 4A) . In line with that, intracellular lactate and citrate levels, as well as, citrate/lactate ratio increased upon LCA treatment (Fig. 4B) . In line with these observations, LCA-induced the expression of a set of OXPHOS genes in 4T1 and MCF7 cells (Fig. 4C , Table 5 ).
Next, we performed pulse-chase metabolomics experiments in MCF7 and 4T1 cells treated with 300 nM LCA. When cells were charged with 13 C-acetate, a metabolite that can fuel the TCA cycle, LCA treatment enhanced the incorporation of 13 C into succinate and malate ( Fig. 4D) suggesting increased flux through the TCA cycle. Next, we fed cells with (Fig. 4E) . We assessed the distribution of (Fig. S4) suggesting a more rapid turning of the TCA cycle. Taken together, LCA treatment induced the TCA cycle and oxidative phosphorylation (OXPHOS) in breast cancer cells.
We assessed components of the cellular energy sensor web and mitochondrial transcriptional regulators to find the roots of the above metabolic changes. LCA-induced expression and activation of positive regulators of mitochondrial oxidative phosphorylation FOXO1, PGC-1β and nuclear respiratory factor-1 (NRF1) (Fig. 5A, Fig S5A) . LCA not only boosted their expression but also enhanced their activation that is evidenced by enhanced nuclear translocation of NRF1 and the higher phosphorylation of ACC (Fig. 5A, B, Fig S5A,   C) . In the in vivo experiments we also observed the LCA-mediated induction of AMPK activity (marked by increased phospho-ACC and phospho-AMPK levels) and enhanced expression of FOXO1 as well, although neither NRF1, nor PGC-1β expression was induced by LCA (Fig. 5C, Fig S5B) .
Subsequently, we assessed whether the induction of the metabolic regulators (NRF1, AMPK, PGCs) have (patho)physiological relevance in humans. Previous studies have underlined the antitumor activity of AMPK and FOXO1 in humans [23, 30, 31] . Using the kmplot.com database we found that high expression of NRF1 in breast cancer tissue is predictive of better survival post-diagnosis (Fig. 5D) . Although no frequent (driver) mutations were found in PGC-1β according to the Intogen database, it did appear that the expression of PGC-1β was reduced in tumor as compared to healthy tissues [32, 33] (Fig. 6A, Table 5 ). NF449 and U73343, unlike CINPA1, efficiently blocked LCA-induced morphological changes (closure of the void areas among cells, epithelial-like morphology) in MCF7 and 4T1 cells (Fig. 6B) . Since NF449
and U73343 are not TGR5-specific inhibitors but block TGR5 signaling, by inhibiting Gsα and phospholipase C, we transiently silenced TGR5 in MCF7 cells (Fig. 6C, D, Fig. S6A , Table   5 ) to provide direct evidence for the involvement of TGR5. Silencing of TGR5 efficiently blocked LCA-induced morphological changes (Fig. 6E) and blocked the LCA-induced increases in the mRNA expression of CYTOCHROME C, ATP5G1 and NDUFB5 mitochondrial markers (Fig 6F, Table 5 ) and markers of AMPK activation (Fig. 6G, Fig.   S6B ). Silencing of VDR receptor had no effect on LCA-induced changes (data not shown). It is also of note that LCA, in the concentrations used in this study, enters biomembranes but does not alter either its dynamical properties or microdomain organization, since neither the diffusion constant (D), nor the confinement time (ƬD) changed even upon 100 μM LCA treatment (Fig. 6H) .
LCA biosynthesis is suppressed in early phases of human breast cancer
We next investigated how bile acid and LCA metabolism relates to breast cancer in humans. LCA is produced through deconjugation of chenodeoxycholic acid (CDCA)
conjugates, followed by a dehydroxylation on carbon 7 by the action of the enzyme 7α/β hydroxysteroid dehydrogenase (7-HSDH) [26] that is the rate-limiting step of LCA formation.
The enzymes involved in the 7-dehydroxylation of bile acids are organized into one operon called the bile acid-inducible (bai) operon wherein the baiH ORF codes for 7-HSDH in most bacterial species [26] .
baiH abundance was assessed by amplifying baiH ORF from fecal DNA using specific primers. To validate this mode of measurement, we treated mice with ciprofloxacin (CPX), an antibiotic that specifically kills aerobic bacteria, while leaving the anaerobic bacteria intact.
When mice were treated with CPX (200 mg/kg q.d. for two weeks) the abundance of staphylococcal, escherichial and pseudomonal baiH (aerobic bacteria) decreased, while the ratio of the baiH of the anaerobic bacteria (Bacteroides fragilis, Clostridium scindens) did not change (Fig. 7) , as expected from the biology of the antibiotic that supports this approach.
Total bile acid, CDCA and LCA levels were reduced in serum from breast cancer patients as compared to age and sex matched healthy individuals (Fig. 8A, B , C, Table 6 ), and we observed a similar trend in all other bile acids we examined (Fig. 8A, Table 6 ). Since both primary and secondary bile acid levels were lower in breast cancer patients, we assessed the ratio between CDCA (the substrate for LCA synthesis) and LCA in human serum. We found a decrease in the LCA/CDCA ratio in breast cancer patients compared to healthy individuals, and this decrease that was more marked when only stage 1 patients
were assessed (Fig. 8D) . At later stages LCA/CDCA ratio normalized and even increased above the ratio of healthy individuals in stage 3 patients. These data are in good correlation with the data of Tang an co-workers [35] demonstrating that glycolithocholate sulphate levels were lower in breast cancer patients compared to controls (additional file 3, line 239).
To get an insight how intestinal LCA biosynthesis is altered in breast cancer patients, we assessed the abundance of the baiH ORF in human fecal DNA from the experimental cohort described in [36] (Table 4, (Fig. 8F) .
Taken together, the bacterial LCA biosynthesis machinery in the intestine is downregulated in breast cancer patients that is very pronounced in the early phase of the disease. Lower capacity to synthesize LCA then contributes to lower LCA levels. These findings together with the observation of Tang and co-workers [35] that glycolithocholate sulphate levels have a significant negative correlation with Ki67 positivity (additional file 9, line 110) in human breast cancer tumors, pointing towards the involvement of bacterial LCA metabolism in human breast cancer pathogenesis.
Discussion
This study nominates LCA, a metabolite of the microbiota, to be synthesized in the gut and thereafter transferred through the bloodstream to the breast where it may be an important player in bringing about an anti-cancer tumor microenvironment. In our studies LCA inhibited the proliferation of breast cancer cells, while it did not interfere with primary cells. In previous studies [37, 38] LCA induced cell death in neuroblastoma, prostate cancer, and MCF7 cells. However, the LCA concentrations utilized in those studies [37, 38] were higher than the one used in our present study, which may explain why we did not observe acute LCA toxicity. As we noted earlier, 100-1000 nM LCA concentration, used in this study, stands closer to the LCA concentrations reported in the breast [27] .
To date no direct, causal relationship had been shown between the microbiome and breast cancer, although studies have suggested an interconnection. Specifically, the gut microbiome had been suggested to facilitate breast cancer progression through deconjugating estrogens making them more prone for reuptake [36, 39] . Goedert and coworkers [36] have assessed microbiome changes in breast cancer patients, finding that postmenopausal breast cancer patients had reduced diversity and altered composition of the gut microbiome compared to closely matched control women. In addition, bacteria were identified on breast duct surfaces, and differences in the microbiome of breast cancer tissue has also been observed [14, [40] [41] [42] . These findings suggest that LCA may be produced by the breast's own microbiota and not only by the gut microbiome. However, the share of the two sources (breast vs. gut) in LCA production is not known.
A causative relationship between the microbiome and breast cancer is further strengthened by the suggestive association between antibiotic treatment and incidence or recurrence of breast cancer [43] [44] [45] [46] [47] [48] . Although the chance of uncontrolled confounding is high and some studies have found no association, evidence for a dose-response relationship between antibiotic exposures and breast cancer incidence has been found [43, 44, [46] [47] [48] .
The correlation between antibiotic use and breast cancer incidence was also found in males [48] . The cancer association has not been tied to a particular antibiotic class, but the strongest correlations have been with tetracyclins and macrolids [45] . These observations support our hypothesis on the relationship between microbiota functions and breast cancer.
Which bacterial species are important in LCA-mediated modulation of breast cancer?
This question is hard to answer at the moment. Goedert and colleagues [36] found that in the gut microbiota breast cancer cases had increased relative abundance of Clostridiaceae, Faecalibacterium, and Ruminococcaceae and decreased Dorea and Lachnospiraceae taxa.
In contrast to that, previous studies showed that anaerobic microbes are instrumental in the production of secondary bile acids, such as LCA [26] . In our study, hereby, we demonstrated decreases in both the aerobic and the anaerobic microbial populations with early stage breast cancer suggesting widespread suppression of the microflora in breast cancer that culminates in decreased LCA production. These imply the contribution of the aerobic flora in LCA synthesis.
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15 Hereby, we demonstrate the antiproliferative effects of LCA against breast cancer cells.
In contrast to that, previous studies have pointed out possible oncogenic properties to secondary bile acid [20] . LCA was shown to possess transforming capacity towards colon epithelial cells [20] , while DCA, that is inactive in our model systems, was shown to reprogram hepatocyte secretome and through that promote hepatocellular carcinoma [16, 49] . Bile acids also are implicated in pharyngeal cancer [50] . The explanation for these differences are yet unknown.
To our best knowledge, this is the first study that provides mechanistic evidence of crosstalk between the microbiome and breast cancer by describing LCA as a bacterial metabolite with antiproliferative effects in breast cancer. It is very likely that other bacterial metabolites that can increase or, like LCA, inhibit the proliferation of breast cancer cells will be described in the future. The fact that the composition of the microbiome influences breast cancer may provide novel approaches to cancer risk estimation and prevention.
Conclusions
In this study we show that a bacterial metabolite, lithocholic acid, can limit the proliferation of breast cancer cells in vitro and in vivo through activating TGR5 receptor, furthermore, in early stages of breast cancer LCA biosynthesis and LCA levels drop suggesting a role for this pathway in human disease. This cohort was published in [36] . Staging of the patients was performed according to [51] .
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